Issued Patents All Time
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10844008 | Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases | Patrick Vermersch, Pascal Carato, Bénédicte Oxombre-Vanteghem, Héléne Zephir, Marion Donnier-Marechal | 2020-11-24 |
| 10807958 | 1,4-bis(3-aminopropyl)piperazine derivative and its use | Nicolas Sergeant, Luc BUEE, Marion GAY, Nicolas Le Fur | 2020-10-20 |
| 10772884 | Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same | Stéphane BURLET, Cécilia ESTRELLA, Mathieu BARRIER, Nicolas Sergeant, Luc BUEE +1 more | 2020-09-15 |
| 10537569 | Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same | Stéphane BURLET, Cécilia ESTRELLA, Mathieu BARRIER, Nicolas Sergeant, Luc BUEE +1 more | 2020-01-21 |
| 10179761 | Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases | Patrick Vermersch, Pascal Carato, Bénédicte Oxombre-Vanteghem, Héléne Zephir, Marion Donnier-Marechal | 2019-01-15 |
| 10017476 | 1,4-bis(3-aminopropyl)piperazine derivative and its use | Nicolas Sergeant, Luc BUEE, Marion GAY, Nicolas Le Fur | 2018-07-10 |
| 9714245 | Carboline compounds usable in the treatment of neurodegenerative diseases | Pascal Carato, Stéphane BURLET, Emilie Nguyen, Philippe Verwaerde, Nicolas Sergeant +1 more | 2017-07-25 |
| 9562018 | Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same | Stéphane BURLET, Cécilia ESTRELLA, Mathieu BARRIER, Nicolas Sergeant, Luc BUEE +1 more | 2017-02-07 |
| 9044478 | Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases | Nicolas Sergeant, Andre Delacourte, Luc BUEE | 2015-06-02 |
| 8680095 | Heterocycle compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the APP metabolism occurs | Andre Delacourte, Stéphane BURLET, Nicolas Lefur | 2014-03-25 |